S Korea authorises use of Novavax COVID-19 vaccine
South Korean vaccine developer SK Bioscience said it will produce the Novavax vaccine
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
WHO body says COVID-19 vaccines ‘may need to be updated’ for Omicron
The technical group, made up of independent experts, said it would consider a change in vaccination composition and stressed that…
Alkem Laboratories to launch technology for Diabetic Foot Ulcer management in India
The technology for Diabetic Foot Ulcer (DFU) management has a high scope of preventing amputations in diabetic patients
India remains a key focus for UPS Healthcare
Having surpassed the 1 billion COVID-19 vaccines delivery milestone in December, Daniel Gagnon, Vice President, Marketing…
Nutra industry and the regulator’s role
The nutra industry needs contribution from every stakeholder to position the industry as one of the core contributors under…
Illumina collaborates with Nashville Biosciences to accelerate medicines development
Nashville Biosciences’ biobank data, coupled with Illumina’s genomics and bioinformatics expertise, will enable scientists and…
US FDA amends J&J vaccine fact sheet to include rare bleeding risk
The amendment fact sheet follows similar moves for the vaccine by other regulators, including that of the European Medicines…
BioNTech says developed method to detect high-risk corona virus variants
The new computational method can analyse genetic sequencing data of new corona virus mutations found in infected people and…
B Medical Systems inaugurates its manufacturing facility in Mundra, Gujarat
Built with an investment of over Rs 100 crores, the facility has an annual production capacity of 100,000 units of medical cold…
Experimental Lilly drug neutralises Omicron in lab; slightly higher risk of diabetes seen in kids…
The drug, known as LY-CoV1404 or Bebtelovimab, "potently" neutralised engineered versions of numerous variants, including Alpha,…
Moderna improves forecast for 2022 sales for COVID-19 vaccine
The company in November said its sales could be in the range of $17 billion to $22 billion in 2022
ICMR refuses using Molnupiravir for COVID treatment, pulmonologists disagree
Dr Bhargava had last week said that Molnupiravir has major safety concerns. He added that WHO and the UK have not included it for…
New study shows novel strategy to improve quality checking of generic drugs
The strategy is likely to improve the regulatory and decision-making aspects related to pharmaceutical products
S.M.A.R.T Pharmaceuticals 2021-2030
Dr Ajaz Hussain, PhD and independent adviser, explains how to make common sense a SMART factory as the political and regulatory…
Caris Life Sciences and HotSpot Therapeutics collaborate to advance precision medicine development…
The partnership with Caris will streamline development of HotSpot’s portfolio by integrating broad tissue and liquid molecular…
Novartis and Molecular Partners report positive topline data from phase-II study for Ensovibep
The secondary endpoint of hospitalisation and/or ER visits related to COVID-19, or death showed an overall 78 per cent reduction…
Pfizer partners with Beam Therapeutics to develop rare disease therapies
Beam will receive $300 million in upfront payment and lead research activities till three new therapy targets are selected for…
Moderna and Carisma collaborate to develop in-vivo engineered CAR-M for oncology
The companies have partnered to discover, develop and commercialise in-vivo engineered Chimeric Antigen Receptor Monocyte (CAR-M)…
Alembic Pharmaceuticals receives US FDA tentative approval for Dronedarone tablets
Dronedarone is indicated to reduce the risk of hospitalisation for atrial fibrillation in patients in sinus rhythm with a history…
AbbVie submits applications for Upadacitinib in to US FDA and EMA
In the trial study, evaluating the efficacy and safety of Upadacitinib in adult patients with nr-axSpA, Upadacitinib met its…